Evidence map›Paper›PMID 34988373›Full record

ArticleGates open research2021

An implementation model for scaling up oral pre-exposure prophylaxis in Kenya:

Daniel Were, Abednego Musau, Mary Mugambi, Marya Plotkin, Mark Kabue, Griffins Manguro, Steven Forsythe, Robert Glabius, Eunice Mutisya, Manya Dotson and 2 more

Abstract read
In one paragraph

Article in Gates open research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daniel WereJhpiego, Kenya, Nairobi, 00800, Kenya.ORCID https://orcid.org/0000-0002-6538-002X
Abednego MusauJhpiego, Kenya, Nairobi, 00800, Kenya.
Mary MugambiDivision of National AIDS and STI Control Program, Nairobi, 00202, Kenya.ORCID https://orcid.org/0000-0002-3684-7161
Marya PlotkinJhpiego, USA, Baltimore, Maryland, 21231, USA.
Mark KabueJhpiego, USA, Baltimore, Maryland, 21231, USA.ORCID https://orcid.org/0000-0002-4918-5558
Griffins ManguroInternational Center for Reproductive Health, Kenya, Mombasa, 80103, Kenya.
Steven ForsytheAvenir Health, Glastonbury, Connecticut, 06033, USA.
Robert GlabiusAvenir Health, Glastonbury, Connecticut, 06033, USA.
Eunice MutisyaPopulation Services Kenya, Nairobi, 00400, Kenya.
Manya DotsonJhpiego, USA, Baltimore, Maryland, 21231, USA.
Kelly CurranJhpiego, USA, Baltimore, Maryland, 21231, USA.
Jason ReedJhpiego, USA, Baltimore, Maryland, 21231, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral pre-exposure prophylaxis (PrEP) is an efficacious way to lower the risk of HIV acquisition among high-risk individuals. Despite the World Health Organization's 2015 recommendation that all persons at substantial risk of HIV infection be provided with access to oral PrEP, the rollout has been slow in many low- and middle-income countries. Initiatives for national rollout are few, and subtle skepticism persists in several countries about the feasibility of national PrEP implementation. We describe the conceptual design of the

Indexed as

adolescent girls and young womendemandkey populationslearning laboratoryOral PrEPownershipscale upsupply

Identifiers

PMID34988373
PMCPMC8669463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.